OCG vs ZKIN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

OCG

47.3
AI Score
VS
ZKIN Wins

ZKIN

56.2
AI Score

Investment Advisor Scores

OCG

47score
Recommendation
HOLD

ZKIN

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric OCG ZKIN Winner
Revenue 1.89M 71.24M ZKIN
Net Income -3.86M -3.99M OCG
Gross Margin 85.7% 5.7% OCG
Net Margin -204.2% -5.6% ZKIN
Operating Income -3.84M -4.25M OCG
ROE -6.0% -16.3% OCG
ROA -5.8% -6.3% OCG
Total Assets 66.53M 62.87M OCG
Cash 32.32M 2.31M OCG
Current Ratio 30.14 1.44 OCG

Relative Price Performance (Last 90 Days)

OCG 1M: +2.2% · 3M: -0.9% ZKIN 1M: -14.5% · 3M: +40.2%

Current Technical Phase

OCG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.8 · Price: $1.66

ZKIN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.4 · Price: $1.50

Fundamentals Snapshot

Metric OCG ZKIN
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E 0.1 —
Revenue (TTM) — —
Revenue Growth 6.2% -0.4%
Gross Margin 0.9% 0.1%
Operating Margin 0.0% -8.0%
EPS 18.65 -1.44
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, ZKIN is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.